News

1. Oct 22, 2018

   Updates to Avelas Biosciences Management Team

   Read more
2. Sep 26, 2018

   Avelas Biosciences to Present at 2018 Cantor Global Healthcare Conference

   Read more
3. Aug 02, 2018

   Avelas Biosciences Initiates Period 2 of Phase 2 Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery

   Read more
4. Jun 14, 2018

   Avelas Biosciences to Present at JMP Securities Annual Life Sciences Conference

   Read more
5. Mar 21, 2018

   Avelas Biosciences to Present at Needham & Company 17th Annual Healthcare Conference

   Read more
6. Mar 13, 2018

   Avelas Biosciences to Present at Oppenheimer 28th Annual Healthcare Conference

   Read more
7. Jan 04, 2018

   Avelas Biosciences Completes Period 1 Patient Enrollment in Phase 2 Study of AVB-620 in Women with Primary, Nonrecurrent Breast Cancer Undergoing Surgery

   Read more
8. Jan 03, 2018

   Avelas Biosciences Broadens Management Team with Key Executive Additions

   Read more
9. Nov 21, 2017

   Avelas Biosciences to Present at Piper Jaffray Healthcare Conference

   Read more

« Previous Page — Next Page »